Injective | Crypto

The contracts mark Injective’s first entry into US-regulated derivatives markets and could help support a spot ETF following a filing from Canary Capital. Chicago-based crypto exchange Bitnomial has launched monthly futures contracts tied to Injective, marking the first US-regulated derivatives product for the Web3 financial ecosystem’s native token. According to Wednesday’s announcement shared with Cointelegraph, the contracts settle in INJ (INJ) with monthly expiries, allowing traders to gain price exposure without holding the underlying asset, and can be margined in crypto or US dollars through Bitnomial’s clearinghouse. The listing also starts a six-month track record that could support a spot exchange-traded fund under US Securities and Exchange Commission (SEC) listing rules. In July, Canary Capital filed for a staked INJ ETF, with Cboe BZX Exchange submitting a corresponding rule change to the SEC. Read more

Approved with 99.89% support, the proposal updates issuance and buyback parameters that govern how INJ is removed from circulation over time. Injective’s protocol community approved a major tokenomics overhaul on Monday, passing a governance proposal with 99.89% support based on staked voting power. Injective is a layer-1 blockchain focused on decentralized finance applications, with INJ (INJ) serving as its native token for staking, governance and transaction fees. The Supply Squeeze proposal (IIP-617) reduces its native token issuance and maintains the network’s buyback-and-burn program, which uses protocol-generated revenue to permanently remove tokens from circulation. Read more

Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens. Injective Protocol, a layer-1 blockchain focused on decentralized finance, is launching onchain pre-IPO perpetual markets, giving global investors access to trade synthetic versions of major private companies such as OpenAI. The new offering allows users to take up to five times leveraged positions on private company valuations directly through Injective, a move the protocol says distinguishes it from centralized pre-IPO products offered by platforms like Robinhood. According to Injective’s announcement on Wednesday, the Pre-IPO perpetuals are powered by onchain data sourced from Seda Protocol, which provides decentralized oracle infrastructure to bring price data onto blockchains, and Caplight, which aggregates private market pricing data for venture-backed companies. Read more

Canary Capital has filed with the U.S. Securities and Exchange Commission to launch the first-ever staked Injective (INJ) exchange-traded fund, aiming to provide institutional investors with regulated access to native on-chain yield. The proposed Canary Staked INJ ETF would actively stake its INJ holdings on the Injective proof-of-stake network, passing staking rewards, currently estimated at […] The post Canary continues altcoin ETF strategy with application to launch Injective fund with staking appeared first on CryptoSlate.